Tamoxifen citrate loaded biodegradable poly(sebacic acid-co-ricinoleic acid) microparticles, in vitro characterization

Journal of Drug Delivery Science and Technology

Volumn 21, Issue 5, 2011, Pages 417-422

  Hiremath, J G ^a   Rudani, C G ^a   Suthar, R V ^a   Domb, A J ^b  

^a East West College of Pharmacy   (India)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Biodegradable; Breast cancer; Microparticles; Poly(sebacic acid co ricinoleic acid); Tamoxifen citrate

Indexed keywords

DRUG CARRIER; POLYMER; RICINOLEIC ACID; SEBACIC ACID; TAMOXIFEN CITRATE;

ARTICLE; BIODEGRADATION; BREAST CANCER; CHEMICAL INTERACTION; CONTROLLED STUDY; IN VITRO STUDY; PARTICLE SIZE; SOLVENT EFFECT; SUSTAINED DRUG RELEASE;

EID: 80055061574     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(11)50067-X     Document Type: Article

References (27)

1. American Cancer Society - Breast cancer facts and figure 2009-2010. - Atlanta, 2010.
2. MacGregor J.I., Jordan V.C. - Basic guide to the mechanisms of antiestrogen action. - Pharmacol. Rev., 50, 151-196, 1998.
3. D'Hondt V., Piccart M. - Controversies in the adjuvant treatment of breast cancer: new adjuvant endocrine treatment strategies. - Annals. Oncol., 15, 23-29, 2004.
4. Michaud L.B. - Adjuvant use of aromatase inhibitors in post-menopausal women with breast cancer. - Am. J. Health Syst. Pharm., 62, 266-273, 2005. (Pubitemid 40403541)
5. Clemons M., Danson S., Howell A. - Tamoxifen (Nolvadex); A review: antitumour treatment. - Cancer Treat. Rev., 28, 165, 2002.
6. Maas R.A., Bruning P.F., Top B. - Growth arrest-associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR, potential early indicators of treatment response. - Cancer Lett., 97, 107, 1995.
7. Lonard D.M., Smith C.L. - Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions. - Steroids., 67, 15, 2002.
8. Jordan V.C., Collins M.M., Rowsby L., Prestwich G.J. - A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. - Endocrinol., 75, 305-316, 1977. (Pubitemid 8219148)
9. Chawla S.J., Amiji M.M. - Biodegradable poly(ε-caprolactone) nanoparticles for tumor targeted delivery of tamoxifen. - Int. J. Pharm., 249, 127-138, 2002.
10. Hiremath J.G., Kusum D.V., Kshama D., Domb A.J. - Biodegradable poly(sebacic acid-co-ricinoleic-ester anhydride) tamoxifen citrate implants: preparation and in vitro characterization. - J. Appl. Polym. Sci., 107, 2745-2754, 2007. (Pubitemid 351238701)
11. Coppi G., Iannuccelli V. - Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system. - Int. J. Pharm., 367, 127-132, 2009.
12. Zhu Z., Yuan Li Y., Li X., Li R., Jia Z., Liu B., Guo W., Wu W., Jiang X. - Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(ε-caprolactone) nanoparticles: preparation and antitumor activity in vivo. - J. Control. Release., 142, 438-446, 2010.
13. Nguyen A., Marsaud V., Bouclier C., Top s., Vessieres A., Pigeon P., Gref R., Legrand P., Jaouen G., Renoir J.M. - Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment. - Int. J. Pharm., 347, 128-135, 2008. (Pubitemid 350186087)
14. Shikanov A., Vaisman B., Shikanov S., Domb A.J. - Efficacy of poly(sebacic acid-co-ricinoleic acid) biodegradable delivery system for intratumoral delivery of paclitaxel. - J. Biomed. Mater. Res. A., 92(4), 1283-1291, 2010.
15. Pawar R.P., Kharat K.R., Domb A.J. - Pasty polymers in cancer drug therapy. - Israel J. Chem., 50 (2), 233-238, 2010.
16. Petersen L.K., Sackett C.K., Narasimhan B. - High-throughput analysis of protein stability in polyanhydride nanoparticles. Acta. Biomater., 6, 3873-3881, 2010.
17. Berkland C., Kipper M.J., Narasimhan B., Kim K., Pack D.W. - Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. - J. Control. Release, 94, 129-141, 2004. (Pubitemid 37542383)
18. Krasko M.Y., Shikanov A., Ezra A., Domb A.J. - Poly(ester anhydride)s prepared by the insertion of ricinoleic acid into poly(sebacic acid). - J. Polym. Sci. Part A: Polym. Chem., 41, 1059-1069, 2003. (Pubitemid 36414612)
19. Agueros M., Ruiz-Gaton L., Vauthier C., Bouchemal K., Espuelas S., Ponchel G., Irache J.M. - Combined hydroxypropyl-β-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel. - Eur. J. Pharm. Sci., 38, 405-413, 2009.
20. Zili Z., Sfar S., Fessi H. - Preparation and characterization of poly(caprolactone) nanoparticles containing griseofulvin. - Int. J. Pharm., 294, 261-267, 2005.
21. Costa P., Lobo J.M.S. - Modeling and comparison of dissolution profiles. - Eur. J. Pharm. Sci., 13, 123-133, 2001. (Pubitemid 32288781)
22. Higuchi W. - Diffussional models useful in the pharmaceutics; drug release rate processes. - J. Pharm. Sci., 56, 315, 1967.
23. Sahana B., Santra K., Basu S., Mukherjee B. - Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in vitro evaluation. - Int. J. Nanomedicine., 5, 621-630, 2010.
24. Shikanov A., Ezra A., Domb A.J. - Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel-effect of additives. - J. Control. Release., 105, 52-67, 2005. (Pubitemid 40805475)
25. Rowe R.C., Sheskey P.J., Quinn M.E. - Handbook of Pharmaceutical Excipients. - Pharmaceutical Press and American Pharmacists Association., Sixth ed., 2009, pp. 424, 222.
26. Mu L., Feng S.S. - Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly(lactic-co-glycolic acid) microparticles prepared by spray drying technique with lipid/cholesterol emulsifiers. - J. Control. Release, 76, 239-254, 2001. (Pubitemid 32913433)
27. Dubernet C. - Thermo analysis of microparticles. - Thermo. Chim. Acta., 248, 259-269, 1995.